Therapeutic Options
Traditionally, allogenous, xenogenous or synthetic scaffold materials are used for bone reconstruction allowing a slow, stepwise in growth of the surrounding healthy bone. The additional treatment of bone defects using patient-own
osteoblasts enhances and accelerates the process of bone regeneration.
The time for bone regeneration and calcification is shortened compared to traditional methods.
So far, the absolute standard for the bone substitution and bone formation in the field of jaw surgery has been the transplantation of autologous bone (autograft) and cadaver bone (allograft) taken from the chin and the iliac cres as well as the use of synthetic carrier materials.
However, this method is paralleled by a considerable volume reduction of the augmented bone area, a low capacity for intrinsic bone formation as well as by a missing integration of scaffold materials into the surrounding healthy bone.
Furthermore, these methods are associated with considerable risks and stress for the patient, such as increased morbidity at the extraction site and related clinical complications.


